Smith Hunter C

Chief Financial OfficerRHYTHM PHARMACEUTICALS, INC. (RYTM) · full profile →Form 4 · filed Feb 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$806K
Net Open-Market Flow
-$806K
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2026Sell(S)800$102.10$82K111K
Feb 19, 2026Sell(S)585$103.28$60K111K
Feb 19, 2026Sell(S)1K$100.27$131K114K
Feb 19, 2026Sell(S)2K$100.92$171K112K
Feb 17, 2026Sell(S)200$100.52$20K117K
Feb 17, 2026Sell(S)200$103.84$21K115K
Feb 17, 2026Sell(S)900$101.70$92K116K
Feb 17, 2026Sell(S)1K$103.00$110K115K
Feb 17, 2026Sell(S)1K$99.42$119K117K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-017729) within minutes of acceptance. Every field above traces to the original document. Verify it directly: